Day One Biopharmaceutical... (DAWN)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

12.75

0.24%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	-	-	-	-	-
Cost of Revenue	383.00K	531.00K	199.00K	155.00K	-
Gross Profit	-383.00K	-531.00K	-199.00K	-155.00K	-
Operating Income	-206.06M	-146.91M	-72.74M	-13.78M	-14.90M
Interest Income	17.19M	4.75M	4.00K	30.00	2.08K
Pretax Income	-188.92M	-142.18M	-72.75M	-43.84M	-16.98M
Net Income	-188.92M	-132.18M	-70.44M	-40.51M	-14.71M
Selling & General & Admin	75.54M	61.29M	29.16M	4.68M	1.01M
Research & Development	130.52M	85.62M	43.58M	9.10M	13.90M
Other Expenses	1.00	-18.00K	-15.00K	-31.00K	-2.00K
Operating Expenses	206.06M	146.91M	72.74M	13.78M	14.90M
Interest Expense	-	4.75M	4.00K	30.00K	2.08M
Selling & Marketing Expenses	-	-	-	-	-
Cost & Expenses	206.06M	146.91M	72.74M	13.78M	14.90M
Income Tax	-	-10.01M	-2.31M	-3.34M	-2.27M
Shares Outstanding (Basic)	79.77M	65.47M	61.95M	61.93M	61.93M
Shares Outstanding (Diluted)	79.77M	65.47M	61.95M	61.93M	61.93M
EPS (Basic)	-2.37	-2.02	-1.14	-0.65	-0.24
EPS (Diluted)	-2.37	-2.02	-1.14	-0.65	-0.24
EBITDA	-206.06M	-141.65M	-72.56M	-43.66M	-2.00K
Depreciation & Amortization	383.00K	531.00K	199.00K	155.00K	14.90M